98 related articles for article (PubMed ID: 11876442)
1. Synthesis and evaluation of 2-chloroethylnitrosoureas of substituted naphthalimides as mixed-function anticancer compounds.
Samanta S; Pain A; Dutta S; Sanyal U
Acta Pol Pharm; 2001; 58(5):351-6. PubMed ID: 11876442
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and evaluation of ethylnitrosoureas of substituted naphthalimides as anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Sharma M; Qazi GN; Sanyal U
Acta Pol Pharm; 2007; 64(1):27-33. PubMed ID: 17665847
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of naphthal-NU, a 2-chloroethylnitrosourea derivative of naphthalimide, as a mixed-function anticancer agent.
Samanta S; Pain A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2002 Mar; 21(1):87-93. PubMed ID: 12071535
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of naphthalmustine, a nitrogen mustard derivative of naphthalimide as a rationally-designed anticancer agent.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Qazi GN; Sanyal U
J Exp Clin Cancer Res; 2003 Sep; 22(3):411-8. PubMed ID: 14582700
[TBL] [Abstract][Full Text] [Related]
6. Antitumor activity of Nitronaphthal-NU, a novel mixed-function agent.
Samanta S; Pain A; Dutta S; Saxena AK; Shanmugavel M; Pandita RM; Qazi GN; Sanyal U
J Exp Ther Oncol; 2005; 5(1):15-22. PubMed ID: 16416597
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of fluorenhymustine as a rationally designed novel anticancer agent.
Samanta S; Pain A; Ghosh M; Dutta S; Sanyal U
Exp Oncol; 2005 Dec; 27(4):279-85. PubMed ID: 16404347
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of dimethoxydop-NU as a novel anti-tumor agent.
Mukherjee A; Dutta S; Sanyal U
J Exp Clin Cancer Res; 2007 Dec; 26(4):489-97. PubMed ID: 18365543
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)-1-methylhydrazines as anticancer agents.
Sanyal U; De R; Dutta S; Das H; Ghost M
Neoplasma; 1993; 40(4):219-22. PubMed ID: 8272148
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the anticancer property of a new alpha-methylene-gamma-lactone derivative of phthalimide.
Sanyal U; Dutta S; Das H
Neoplasma; 1995; 42(3):129-32. PubMed ID: 7637822
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of antitumor activity of arylamides and cyclohexylamides of isomeric 3-chloro-4-(2-chloroethylthio)butanoic- and 4-chloro-3-(2-chloroethylthio)butanoic acids.
Vektariene A; Palaima A; Simkeviciene V
Arzneimittelforschung; 1997 Feb; 47(2):217-22. PubMed ID: 9079243
[TBL] [Abstract][Full Text] [Related]
13. Antitumor activity of an alkylating derivative of dipyridamole.
Andreani A; Bossa R; Fraccari A; Galatulas I; Ninci MA; Rambaldi M
Anticancer Res; 1996; 16(4A):1831-3. PubMed ID: 8712709
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of phthalmustine, a new anticancer compound. II. Tumor inhibitory effect in murine Ehrlich ascites carcinoma and sarcoma-180.
Bhattacharya S; Ghosh M; Sadhu U; Dutta S; Sanyal U
Neoplasma; 1996; 43(3):209-13. PubMed ID: 8841510
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of beta-tethymustine, a new anticancer compound, in murine tumour models.
Ghosh M; Bhattacharya S; Sadhu U; Dutta S; Sanyal U
Cancer Lett; 1997 Oct; 119(1):7-12. PubMed ID: 18372515
[TBL] [Abstract][Full Text] [Related]
16. Bis-naphthalimides: a new class of antitumor agents.
Braña MF; Castellano JM; Morán M; Pérez de Vega MJ; Romerdahl CR; Qian XD; Bousquet P; Emling F; Schlick E; Keilhauer G
Anticancer Drug Des; 1993 Aug; 8(4):257-68. PubMed ID: 8240655
[TBL] [Abstract][Full Text] [Related]
17. Genotoxic, cytostatic, antineoplastic and apoptotic effects of newly synthesized antitumour steroidal esters.
Karapidaki I; Bakopoulou A; Papageorgiou A; Iakovidou Z; Mioglou E; Nikolaropoulos S; Mourelatos D; Lialiaris T
Mutat Res; 2009 Apr; 675(1-2):51-9. PubMed ID: 19386248
[TBL] [Abstract][Full Text] [Related]
18. Development of differential cytotoxic compounds containing nitrosourea and benzothiazine nucleus.
Nyati MK; Rai D; Gupta RR; Dev PK
In Vivo; 1997; 11(1):95-9. PubMed ID: 9067778
[TBL] [Abstract][Full Text] [Related]
19. Novel bifunctional alkylating agents, 5,10-dihydropyrrolo[1,2-b]isoquinoline derivatives, synthesis and biological activity.
Chaniyara R; Kapuriya N; Dong H; Lee PC; Suman S; Marvania B; Chou TC; Lee TC; Kakadiya R; Shah A; Su TL
Bioorg Med Chem; 2011 Jan; 19(1):275-86. PubMed ID: 21144756
[TBL] [Abstract][Full Text] [Related]
20. Preclinical studies of steroid-linked nitrosoureas in murine pancreatic adenocarcinoma PANO2.
Papageorgiou A; Lialiaris T; Stergiou E; Stergiou I; Tsigris C; Kourti A; Geromichalos G; Stravoravdi P; Trafalis D; Athanassiou AE; Pitsas A; Camoutsis Ch
J BUON; 2008; 13(2):235-9. PubMed ID: 18555471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]